Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications from the Centre for Immuno-Oncology

Fcγ receptors and immunomodulatory antibodies in cancer.

Galvez-Cancino F. et al, (2024), Nature reviews. Cancer, 24, 51 - 71

The tumour ecology of quiescence: Niches across scales of complexity.

Castillo SP. et al, (2023), Seminars in cancer biology, 92, 139 - 149

Body composition and lung cancer-associated cachexia in TRACERx.

Al-Sawaf O. et al, (2023), Nature medicine, 29, 846 - 858

Evolutionary characterization of lung adenocarcinoma morphology in TRACERx.

Karasaki T. et al, (2023), Nature medicine, 29, 833 - 845

Genomic-transcriptomic evolution in lung cancer and metastasis.

Martínez-Ruiz C. et al, (2023), Nature, 616, 543 - 552

Lung adenocarcinoma promotion by air pollutants.

Hill W. et al, (2023), Nature, 616, 159 - 167

The evolution of lung cancer and impact of subclonal selection in TRACERx.

Frankell AM. et al, (2023), Nature, 616, 525 - 533

The evolution of non-small cell lung cancer metastases in TRACERx.

Al Bakir M. et al, (2023), Nature, 616, 534 - 542

Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA.

Abbosh C. et al, (2023), Nature, 616, 553 - 562

Deciphering immunoregulatory vulnerabilities in human cancers.

Gálvez-Cancino F. et al, (2022), Nature immunology, 23, 995 - 996

Load More